Financials Vivos Inc.

Equities

RDGL

US92858K2042

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 01:28:57 15/05/2024 am IST 5-day change 1st Jan Change
0.2008 USD +1.49% Intraday chart for Vivos Inc. +11.87% +177.73%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 8.742 6.821 30.61 29.03 16.05 27.78
Enterprise Value (EV) 1 8.791 7.587 30.05 27.43 14.34 26.19
P/E ratio -0.42 x -4.03 x -24.6 x -10.9 x -6.32 x -9.21 x
Yield - - - - - -
Capitalization / Revenue - 71,79,78,421 x 4,37,34,62,286 x 1,95,02,13,005 x 43,96,07,332 x 1,42,46,16,000 x
EV / Revenue - 79,86,10,526 x 4,29,35,64,286 x 1,84,23,25,385 x 39,28,64,544 x 1,34,29,60,256 x
EV / EBITDA -3.53 x - - - - -
EV / FCF -2.67 x -21.1 x -41.5 x -78.3 x -52.6 x -80.9 x
FCF Yield -37.4% -4.75% -2.41% -1.28% -1.9% -1.24%
Price to Book -0.8 x -0.58 x -3.17 x -3.57 x -2.02 x -3.39 x
Nbr of stocks (in thousands) 1,51,774 1,84,346 2,90,182 3,42,368 3,61,379 3,84,233
Reference price 2 0.0576 0.0370 0.1055 0.0848 0.0444 0.0723
Announcement Date 25/03/19 28/04/20 24/03/21 07/03/22 01/03/23 18/03/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - 0.0095 0.007 0.0149 0.0365 0.0195
EBITDA 1 -2.488 - - - - -
EBIT 1 -2.49 -1.33 -0.6725 -2.502 -2.518 -2.793
Operating Margin - -13,999.78% -9,607.44% -16,805.25% -6,898.13% -14,323.83%
Earnings before Tax (EBT) 1 -7.703 -1.61 -0.957 -2.528 -2.47 -2.895
Net income 1 -7.703 -1.61 -0.957 -2.528 -2.47 -2.895
Net margin - -16,948.39% -13,671.31% -16,979.69% -6,767.75% -14,844.89%
EPS 2 -0.1388 -0.009190 -0.004295 -0.007757 -0.007028 -0.007849
Free Cash Flow 1 -3.287 -0.3601 -0.7245 -0.3502 -0.2727 -0.3236
FCF margin - -3,790.56% -10,350.53% -2,352.65% -747.23% -1,659.59%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 25/03/19 28/04/20 24/03/21 07/03/22 01/03/23 18/03/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.05 0.77 - - - -
Net Cash position 1 - - 0.56 1.61 1.71 1.59
Leverage (Debt/EBITDA) -0.0194 x - - - - -
Free Cash Flow 1 -3.29 -0.36 -0.72 -0.35 -0.27 -0.32
ROE (net income / shareholders' equity) 296% 133% 132% -337% -158% -191%
ROA (Net income/ Total Assets) -9,670% -2,754% -85.7% -122% -93.2% -104%
Assets 1 0.0797 0.0585 1.117 2.079 2.651 2.78
Book Value Per Share 2 -0.0700 -0.0600 -0.0300 -0.0200 -0.0200 -0.0200
Cash Flow per Share 2 0 0 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 25/03/19 28/04/20 24/03/21 07/03/22 01/03/23 18/03/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW